Patent · US Active

Pyrazolo[1,5-a]pyrimidine compound

US10227349B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 29, 2017
Grant dateMar 12, 2019
Priority date—
Expiry dateAug 29, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure provides pyrazolo[1,5-a]pyrimidine compounds, and pharmaceutically acceptable salts thereof, having protease-activated receptor 2 (PAR2) inhibitory action, pharmaceutical compositions containing the same, and methods of treatment using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.